First PacTrust Bancorp, Inc. (NASDAQ:FPTB), the holding company for Pacific Trust Bank (the �Bank�), announced that it has received an investment of $32.0 million in the Company�s preferred stock from the United States Department of the Treasury under the Small Business Lending Fund (the �SBLF�). The SBLF is a $30 billion voluntary program intended to encourage small business lending by providing capital to qualified community banks at favorable rates.
�We are pleased to have completed the SBLF capital infusion in support of our small business lending operations,� commented Gregory A. Mitchell, President and CEO. Mr. Mitchell added, �We believe our participation in the SBLF program is a great opportunity for the Company and the Bank to continue to meet the credit needs of the small business community and also to benefit our stockholders.�
As of June 30, 2011, the Company had consolidated total assets of $882.3 million and stockholders� equity of $160.5 million. The Company�s book value per share was $13.91 as of June 30, 2011, based upon 11,520,067 shares of common stock outstanding as of that date.
First PacTrust Bancorp, Inc. is the parent holding company of Pacific Trust Bank and is headquartered in Chula Vista, California. The Bank currently operates through 11 banking offices serving primarily San Diego and Riverside Counties in California. The Bank provides customers with the convenience of banking at more than 4,300 branch locations throughout the United States as part of the CU Services Network and 28,000 fee-free ATM locations through the CO-OP ATM Network.
More about FPTB at www.firstpactrustbancorp.com
Bioenergy includes solid biomass (i.e., forest product wastes, agricultural residues and wastes, and energy crops), biogas, liquid biofuels, and the organic component of industrial waste and municipal solid waste. Biomass-derived fuels are by-products of industrial or agricultural processes or fuels made from biomass feedstock.
An on-site biomass-fueled power plant efficiently converts wood and agricultural waste into energy that can be used for electricity and heat, making your business stronger, your bottom line healthier, and our environment cleaner. Discover the benefits of taking the power into your own hands.
Cleantech Transit Inc. (�Cleantech�) (OTC.BB:CLNO) was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company�s manufacturing clients worldwide.
Cleantech Transit, Inc. is pleased to announce it has met its funding requirement to secure the Company�s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
Aceto Corp. (Nasdaq:ACET) a global leader in the marketing and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, announced that it will issue its financial results of operations for its 2011 fiscal fourth quarter and year-ended June 30, 2011 before the stock market opens on Friday, September 9, 2011. That morning, at 9:00 am ET, Albert Eilender, Vincent Miata, Ronald Gold and Douglas Roth will conduct a conference call.
Aceto Corporation, together with its subsidiaries, engages in sourcing, quality assurance, regulatory support, marketing, and distributing chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals, and crop protection products.
Stereotaxis Inc. (Nasdaq:STXS) announced that executive management will present at the Stifel Nicolaus Healthcare Conference to be held September 7-9, 2011 in Boston, MA. Michael P. Kaminski, President and Chief Executive Officer of Stereotaxis, is scheduled to present an overview of the Company on Wednesday, September 7, 2011 at 4:25 p.m. ET. A live webcast and subsequent archived replay of the presentation will be accessible at www.stereotaxis.com, in the “Investor Relations” section under “Events & Presentations.”
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias.
rue21, Inc. (Nasdaq:RUE) announced its financial results for the second quarter and fiscal year-to-date ended July 30, 2011. Net sales increased 20.9% to $172.8 million, compared to $143.0 million in the second quarter of fiscal 2010 ended July 31, 2010. Comparable store sales for the quarter were flat. The company opened 34 stores, closed 1 store, and converted an additional 14 stores to the larger rue21 etc! format compared to opening 31 new stores, closing 1 store, and converting 9 stores to the etc! format in the second quarter of fiscal 2010. The Company ended the quarter with 710 stores. Gross margin increased 90 bps to 39.1% from 38.2% in the second quarter of fiscal 2010, driven by a strong merchandise margin. Selling, general and administrative expenses were $48.9 million or 28.3% of sales. This compares to $38.7 million or 27.1% of sales in the second quarter of fiscal 2010.
rue21 is a leading specialty apparel retailer offering exclusive branded merchandise and the newest trends at a great value. The Company operates 722 stores in 46 states. Learn more at www.rue21.com.
No comments:
Post a Comment